Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MAC Pharmaceutical Investing
pSivida Announces Transformative Acquisition of Icon Bioscience and Growth Capital Financing with Essex Woodlands Healthcare Partners Pharmaceutical Investing
Immunovaccine Announces Initiation of Patient Dosing in Investigator-Sponsored Phase 2 Clinical Trial Biotech Investing
Xenon Pharmaceuticals Confirms Closing of Transaction with Teva and Announces Preferred Share Exchange Agreement with BVF Partners L.P. Pharmaceutical Investing
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2017 Financial and Operating Results Biotech Investing
